Gene expression alterations in brain areas of intracerebroventricular streptozotocin treated rat

Journal of Alzheimer's Disease

Volumn 9, Issue 3, 2006, Pages 261-271

  Grünblatt, Edna ^a   Koutsilieri, Eleni ^a   Hoyer, Siegfried ^b   Riederer, Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alzheimer's disease; Diabetes; Insulin; Neurodegeneration; Quantitative RT PCR; Rat; Streptozotocin

Indexed keywords

ALPHA INTEGRIN; BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUCOSE; GROWTH FACTOR; INSULIN; INTEGRIN ALPHA M; METALLOTHIONEIN I; METALLOTHIONEIN II; NERVE GROWTH FACTOR IB; STREPTOZOCIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN METABOLISM; BRAIN REGION; CEREBELLUM; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DIABETES MELLITUS; DOWN REGULATION; FEEDING; GENE EXPRESSION; GLUCOSE METABOLISM; IMMEDIATE EARLY GENE; INFLAMMATION; MALE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 33747399431     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-9305     Document Type: Article

References (103)

1. L. Acarin, B. Gonzalez, J. Hidalgo, A.J. Castro and B. Castellano, Primary cortical glial reaction versus secondary thalamic glial response in the excitotoxically injured young brain: astroglial response and metallothionein expression, Neuroscience 92 (1999), 827-839.
2. P.A. Adlard, A.K. West and J.C. Vickers, Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer's disease, Neurobiol Dis 5 (1998), 349-356.
3. E.L. Air, S.C. Benoit, K.A. Blake Smith, D.J. Clegg and S.C. Woods, Acute third ventricular administration of insulin decreases food intake in two paradigms, Pharmacol Biochem Behav 72 (2002), 423-429.
4. S.K. Akkina, C.L. Patterson and D.E. Wright, GDNF rescues nonpeptidergic unmyelinated primary afferents in streptozotocin-treated diabetic mice, Exp Neurol 167 (2001), 173-182.
5. A. Alzheimer, Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und psychiatrisch-gerichtliche Medizin 64 (1907), 146-148.
6. M. Aragno, E. Tamagno, V. Gatto, E. Brignardello, S. Parola, O. Danni and G. Boccuzzi, Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress. Free Radic Biol Med 26 (1999), 1467-1474.
7. E. Arenas, M. Trupp, P. Akerud and C.F. Ibanez, GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo, Neuron 15 (1995), 1465-1473.
8. M.L. Barbaccia, D.M. Chuang and E. Costa, Is insulin a neuromodulator? Adv Biochem Psychopharmacol 33 (1982), 511-518.
9. D.G. Baskin, B. Brewitt, D.A. Davidson, E. Corp, T. Paquette, D.P. Figlewicz, T.K. Lewellen, M.K. Graham, S.G. Woods and D.M. Dorsa, Quantitative autoradiographic evidence for insulin receptors in the choroid plexus of the rat brain, Diabetes 35 (1986), 246-249.
10. I. Bastar, S. Seckin, M. Uysal and G. Aykac-Toker, Effect of streptozotocin on glutathione and lipid peroxide levels in various tissues of rats. Res Commun Mol Pathol Pharmacol 102 (1998), 265-272.
11. A. Blokland and J. Jolles, Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin, Pharmacol Biochem Behav 44 (1993), 491-494.
12. F.T. Boyd, Jr., D.W. Clarke and M.K. Raizada, Insulin inhibits specific norepinephrine uptake in neuronal cultures from rat brain, Brain Res 398 (1986), 1-5.
13. D.A. Butterfield, J. Drake, C. Pocernich and A. Castegna, Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide, Trends Mol Med 7 (2001), 548-554.
14. E. Carro and I. Torres-Aleman, The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease, Eur J Pharmacol 490 (2004), 127-133.
15. H. Chen, E.C. Carlson, L. Pellet, J.T. Moritz and P.N. Epstein, Overexpression of metallothionein in pancreatic beta-cells reduces streptozotocin-induced DNA damage and diabetes, Diabetes 50 (2001), 2040-2046.
16. S. Choudhuri, K.K. Kramer, N.E. Berman, T.P. Dalton, G.K. Andrews and C.D. Klaassen, Constitutive expression of metallothionein genes in mouse brain, Toxicol Appl Pharmacol 131 (1995), 144-154.
17. J.A. Christianson, J.T. Riekhof and D.E. Wright, Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice, Exp Neurol 179 (2003), 188-199.
18. J.A. Christianson, J.M. Ryals, K.E. McCarson and D.E. Wright, Beneficial actions of neurotrophin treatment on diabetes-induced hypoalgesia in mice, J Pain 4 (2003), 493-504.
19. P. Coyle, J.C. Philcox, L.C. Carey and A.M. Rofe, Metallothio nein: the multipurpose protein, Cell Mol Life Sci 59 (2002), 627-647.
20. S. Craft, S. Asthana, G. Schellenberg, L. Baker, M. Cherrier, A.A. Boyt, R.N. Martins, M. Raskind, E. Peskind and S. Plymate, Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype, Ann N Y Acad Sci 903 (2000), 222-228.
21. S. Craft, S. Asthana, G. Schellenberg, M. Cherrier, L. D. Baker, J. Newcomer, S. Plymate, S. Latendresse, A. Petrova, M. Raskind, E. Peskind, C. Lofgreen and K. Grimwood, Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender. Neuroendocrinology 70 (1999), 146-152.
22. P. Fernyhough, L.T. Diemel, W.J. Brewster and D.R. Tomlinson, Altered neurotrophin mRNA levels in peripheral nerve and skeletal muscle of experimentally diabetic rats, J Neurochem 64 (1995), 1231-1237.
23. L. Frölich and S. Hoyer, [Etiologic and pathogenetic heterogeneity of Alzheimer disease], Nervenarzt 73 (2002), 422-427.
24. J. Galon, D. Franchimont, N. Hiroi, G. Frey, A. Boettner, M. Ehrhart-Bornstein, J.J. O'Shea, G.P. Chrousos and S.R. Bornstein, Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells, Faseb J 16 (2002), 61-71.
25. L. Gasparini, W.J. Netzer, P. Greengard and H. Xu, Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol Sci 23 (2002), 288-293.
26. K. Gerozissis, Brain insulin: regulation, mechanisms of action and functions, Cell Mol Neurobiol 23 (2003), 1-25.
27. O. Ghribi, M.M. Herman, M.S. Forbes, D.A. DeWitt and J. Savory, GDNF protects against aluminum-induced apoptosis in rabbits by upregulating Bcl-2 and Bcl-XL and inhibiting mitochondrial Bax translocation, Neurobiol Dis 8 (2001), 764-773.
28. W.H. Gispen and G.J. Biessels, Cognition and synaptic plasticity in diabetes mellitus, Trends Neurosci 23 (2000), 542-549.
29. E. Grünblatt, S. Hoyer and P. Riederer, Gene expression profile in streptozotocin rat model for sporadic Alzheimer's disease, J Neural Transm 111 (2004), 367-386.
30. J. Havrankova, D. Schmechel, J. Roth and M. Brownstein, Identification of insulin in rat brain, Proc Natl Acad Sci USA 75 (1978), 5737-5741.
31. K.A. Heidenreich, N.R. Zahniser, P. Berhanu, D. Brandenburg and J.M. Olefsky, Structural differences between insulin receptors in the brain and peripheral target tissues, J Biol Chem 258 (1983), 8527-8530.
32. R. Hellweg, R. Nitsch, C. Hock, M. Jaksch and S. Hoyer, Nerve growth factor and choline acetyltransferase activity levels in the rat brain following experimental impairment of cerebral glucose and energy metabolism, J Neurosci Res 31 (1992), 479-486.
33. N. Henneberg and S. Hoyer, Short-term or long-term intracerebroventricular (i.c.v.) infusion of insulin exhibits a discrete anabolic effect on cerebral energy metabolism in the rat, Neurosci Lett 175 (1994), 153-156.
34. J. Hidalgo, E. Belloso, J. Hernandez, T. Gasull and A. Molinero, Role of Glucocorticoids on Rat Brain Metallothionein-I and -III Response to Stress, Stress 1 (1997), 231-240.
35. C. Holmes, Genotype and phenotype in Alzheimer's disease. Br J Psychiatry 180 (2002), 131-134.
36. M.J. Holness, M.L. Langdown and M.C. Sugden, Early-life programming of susceptibility to dysregulation of glucose metabolism and the development of Type 2 diabetes mellitus, Biochem J 349 (2000), 657-665.
37. S. Hoyer, Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications, Adv Exp Med Biol 541 (2004), 135-152.
38. S. Hoyer and L. Frölich, Brain function and insulin signal transduction in sporadic Alzheimer's disease, in: Research Progress in Alzheimer's Disease and Dementia, M. Sich, ed., Nova Science, New York, 2006.
39. S. Hoyer, H. Lannert, M. Noldner and S.S. Chatterjee, Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761), J Neural Transm 106 (1999), 1171-1188.
40. E.A. Jonas, R.J. Knox, T.C. Smith, N.L. Wayne, J.A. Connor and L.K. Kaczmarek, Regulation by insulin of a unique neuronal Ca2+ pool and of neuropeptide secretion, Nature 385 (1997), 343-346.
41. E.G. Jones, D.W. Choi and L.M. Mendell, Neurosci Newslett (1999).
42. A. M. Joussen, S. Huang, V. Poulaki, K. Camphausen, W.D. Beecken, B. Kirchhof and A.P. Adamis, In vivo retinal gene expression in early diabetes, Invest Ophthalmol Vis Sci 42 (2001), 3047-3057.
43. C.U. Kloss, M. Bohatschek, G.W. Kreutzberg and G. Raivich, Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in the mouse brain and in cell culture, Exp Neurol 168 (2001), 32-46.
44. Z. Lackovic, M. Salkovic, Z. Kuci and M. Relja, Effect of long-lasting diabetes mellitus on rat and human brain monoamines, J Neurochem 54 (1990), 143-147.
45. H. Lannert and S. Hoyer, Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats, Behav Neurosci 112 (1998), 1199-1208.
46. H. Lannert, P. Wirtz, V. Schuhmann and R. Galmbacher, Effects of Estradiol (-17beta) on learning, memory and cerebral energy metabolism in male rats after intracerebroventricular administration of streptozotocin, J Neural Transm 105 (1998), 1045-1063.
47. B.E. Levin, Factors promoting and ameliorating the development of obesity, Physiol Behav 86 (2005), 633-639.
48. Q. Liang, E.C. Carlson, R.V. Donthi, P.M. Kralik, X. Shen and P.N. Epstein, Overexpression of metallothionein reduces diabetic cardiomyopathy, Diabetes 51 (2002), 174-181.
49. V.K. Lishko, V.P. Yakubenko and T.P. Ugarova, The interplay between integrins alphaMbeta2 and alpha5beta1 during cell migration to fibronectin, Exp Cell Res 283 (2003), 116-126.
50. J.F. Loring, X. Wen, J.M. Lee, J. Seilhamer and R. Somogyi, A gene expression profile of Alzheimer's disease, DNA Cell Biol 20 (2001), 683-695.
51. W.J. Lukiw and N.G. Bazan, Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex, J Neurosci Res 50 (1997), 937-945.
52. W.J. Lukiw and N.G. Bazan, Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex, J Neurosci Res 53 (1998), 583-592.
53. K. Maruyama, T. Tsukada, N. Ohkura, S. Bandoh, T. Hosono and K. Yamaguchi, The NGFI-B subfamily of the nuclear receptor superfamily (review), Int J Oncol 12 (1998), 1237-1243.
54. M.P. Mattson, W. Duan, S.L. Chan, A. Cheng, N. Haughey, D.S. Gary, Z. Guo, J. Lee and K. Furukawa, Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior, Neurobiol Aging 23 (2002), 695-705.
55. G. Mayer, R. Nitsch and S. Hoyer, Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats, Brain Res 532 (1990), 95-100.
56. A.L. McCall, Diabetes mellitus and the central nervous system, Int Rev Neurobiol 51 (2002), 415-453.
57. B.S. McEwen and L.P. Reagan, Glucose transporter expression in the central nervous system: relationship to synaptic function, Eur J Pharmacol 490 (2004), 13-24.
58. C. Messier, Glucose improvement of memory: a review, Eur J Pharmacol 490 (2004), 33-57.
59. T. Nakagawa, M. Ono-Kishino, E. Sugaru, M. Yamanaka, M. Taiji and H. Noguchi, Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice, Diabetes Metab Res Rev 18 (2002), 185-191.
60. T. Nakagawa, A. Tsuchida, Y. Itakura, T. Nonomura, M. Ono, F. Hirota, T. Inoue, C. Nakayama, M. Taiji and H. Noguchi, Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice, Diabetes 49 (2000), 436-444.
61. R. Nitsch and S. Hoyer, Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex, Neurosci Lett 128 (1991), 199-202.
62. C.R. Park, Cognitive effects of insulin in the central nervous system, Neurosci Biobehav Rev 25 (2001), 311-323.
63. C.R. Park, R.J. Seeley, S. Craft and S.C. Woods, Intracerebroventricular insulin enhances memory in a passive-avoidance task, Physiol Behav 68 (2000), 509-514.
64. M.S. Petrisic, S.J. Augood and R.J. Bicknell, Monoamine transporter gene expression in the central nervous system in diabetes mellitus, J Neurochem 68 (1997), 2435-2541.
65. K. Plaschke and S. Hoyer, Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus, Int J Dev Neurosci 11 (1993), 477-483.
66. J. Prickaerts, A. Blokland, W. Honig, F. Meng and J. Jolles, Spatial discrimination learning and choline acetyltransferase activity in streptozotocin-treated rats: effects of chronic treatment with acetyl-L-carnitine, Brain Res 674 (1995), 142-146.
67. E. Recio-Pinto, F.F. Lang and D.N. Ishii, Insulin and insulin-like growth factor II permit nerve growth factor binding and the neurite formation response in cultured human neuroblastoma cells, Proc Natl Acad Sci USA 81 (1984), 2562-2566.
68. A.A. Rensink, I. Otte-Holler, H.J. ten Donkelaar, R.M. De Waal, B. Kremer and M.M. Verbeek, Differential gene expression in human brain pericytes induced by amyloid-beta protein, Neuropathol Appl Neurobiol 30 (2004), 279-291.
69. C.C. Rerup, Drugs producing diabetes through damage of the insulin secreting cells, Pharmacol Rev 22 (1970), 485-518.
70. A.N. Richarz and P. Bratter, Speciation analysis of trace elements in the brains of individuals with Alzheimer's disease with special emphasis on metallothioneins, Anal Bioanal Chem 372 (2002), 412-417.
71. S. Rogan and C.F. Lippa, Alzheimer's disease and other dementias: a review, Am J Alzheimers Dis Other Demen 17 (2002), 11-17.
72. M. Salkovic-Petrisic and Z. Lackovic, Intracerebroventricular administration of betacytotoxics alters expression of brain monoamine transporter genes, J Neural Transm 110 (2003), 15-29.
73. M. Salkovic-Petrisic, F. Tribl, M. Schmidt, S. Hoyer and P. Riederer, Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway, J Neurochem 96 (2006), 1005-1015.
74. M.W. Schwartz, D.P. Figlewicz, D.G. Baskin, S.C. Woods and D. Porte, Jr., Insulin in the brain: a hormonal regulator of energy balance, Endocr Rev 13 (1992), 387-414.
75. E. Senba and T. Ueyama, Stress-induced expression of immediate early genes in the brain and peripheral organs of the rat, Neurosci Res 29 (1997), 183-207.
76. M. Sharma and Y.K. Gupta, Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment, Life Sci 68 (2001), 1021-1029.
77. M. Sharma and Y.K. Gupta, Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats, Life Sci 71 (2002), 2489-2498.
78. B.S. Shastry, Neurodegenerative disorders of protein aggregation, Neurochem Int 43 (2003), 1-7.
79. G.J. Siegel and N.B. Chauhan, Neurotrophic factors in Alzheimer's and Parkinson's disease brain, Brain Res Brain Res Rev 33 (2000), 199-227.
80. J.L. Sievenpiper, A.L. Jenkins, D.L. Whitham and V. Vuksan, Insulin resistance: concepts, controversies, and the role of nutrition, Can J Diet Pract Res 63 (2002), 20-32.
81. R. Sladek and V. Giguere, Orphan nuclear receptors: an emerging family of metabolic regulators, Adv Pharmacol 47 (2000), 23-87.
82. E.Y. Snyder and S.U. Kim, Insulin: is it a nerve survival factor? Brain Res 196 (1980), 565-571.
83. R. Sreekumar, P. Halvatsiotis, J.C. Schimke and K.S. Nair, Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment, Diabetes 51 (2002), 1913-1920.
84. P.H. St George-Hyslop, Genetic factors in the genesis of Alzheimer's disease, Ann N Y Acad Sci 924 (2000), 1-7.
85. M.W. Strachan, Insulin and cognitive function, Lancet 362 (2003), 1253.
86. J. Svaren, T. Ehrig, S.A. Abdulkadir, M.U. Ehrengraber, M.A. Watson and J. Milbrandt, EGR1 target genes in prostate carcinoma cells identified by microarray analysis, J Biol Chem 275 (2000), 38524-38531.
87. Y. Takada, T. Kamata, A. Irie, W. Puzon-McLaughlin and X.P. Zhang, Structural basis of integrin-mediated signal transduction, Matrix Biol 16 (1997), 143-151.
88. G. Taubes, Neuroscience. Insulin insults may spur Alzheimer's disease, Science 301 (2003), 40-41.
89. D. Terwel, J. Prickaerts, F. Meng and J. Jolles, Brain enzyme activities after intracerebroventricular injection of streptozotocin in rats receiving acetyl-L-carnitine. Eur J Pharmacol 287 (1995), 65-71.
90. L.A. Ugozzoli, D. Chinn and K. Hamby, Fluorescent multicolor multiplex homogeneous assay for the simultaneous analysis of the two most common hemochromatosis mutations, Anal Biochem 307 (2002), 47-53.
91. H. von der Kammer, C. Demiralay, B. Andresen, C. Albrecht, M. Mayhaus and R.M. Nitsch, Regulation of gene expression by muscarinic acetylcholine receptors, Biochem Soc Symp (2001), 131-140.
92. J. Wada, H. Zhang, Y. Tsuchiyama, K. Hiragushi, K. Hida, K. Shikata, Y.S. Kanwar and H. Makino, Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis, Kidney Int 59 (2001), 1363-1373.
93. Q. Wan, Z.G. Xiong, H.Y. Man, C.A. Ackerley, J. Braunton, W.Y. Lu, L.E. Becker, J.F. MacDonald and Y.T. Wang, Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin, Nature 388 (1997), 686-690.
94. G.S. Watson and S. Craft, The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment, CNS Drugs 17 (2003), 27-45.
95. M. Weinstock and S. Shoham, Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity, J Neural Transm 111 (2004), 347-366.
96. S.C. Woods, E.C. Lotter, L.D. McKay and D. Porte, Jr., Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons, Nature 282 (1979), 503-505.
97. J. Yang and M.G. Cherian, Protective effects of metallothionein on streptozotocin-induced diabetes in rats, Life Sci 55 (1994), 43-51.
98. P. Zambenedetti, R. Giordano and P. Zatta, Metallothioneins are highly expressed in astrocytes and microcapillaries in Alzheimer's disease, J Chem Neuroanat 15 (1998), 21-26.
99. W. Zhao, H. Chen, H. Xu, E. Moore, N. Meiri, M.J. Quon and D.L. Alkon, Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats, J Biol Chem 274 (1999), 34893-34902.
100. W.Q. Zhao and D.L. Alkon, Role of insulin and insulin receptor in learning and memory, Mol Cell Endocrinol 177 (2001), 125-134.
101. W.Q. Zhao, H. Chen, M.J. Quon and D.L. Alkon, Insulin and the insulin receptor in experimental models of learning and memory, Eur J Pharmacol 490 (2004), 71-81.
102. W.Q. Zhao, G.H. Chen, H. Chen, A. Pascale, L. Ravindranath, M.J. Quon and D.L. Alkon, Secretion of Annexin II via activation of insulin receptor and insulin-like growth factor receptor, J Biol Chem 278 (2003), 4205-4215.
103. W.Q. Zhao, L. Ravindranath, A.S. Mohamed, O. Zohar, G.H. Chen, C.G. Lyketsos, R. Etcheberrigaray and D.L. Alkon, MAP kinase signaling cascade dysfunction specific to Alzheimer's disease in fibroblasts, Neurobiol Dis 11 (2002), 166-183.